Ogilvie Christian M, Crawford Eileen A, Hosalkar Harish S, King Joseph J, Lackman Richard D
Department of Orthopaedic Surgery, University of Pennsylvania, Philadelphia, PA 19106-6192, USA.
Clin Orthop Relat Res. 2009 Oct;467(10):2685-90. doi: 10.1007/s11999-009-0726-9. Epub 2009 Feb 13.
Osteoarticular allograft reconstruction after extremity tumor resection has been shown to have a high rate of complications. Although good functional results have been seen, long-term outcomes have not been well studied. We performed a retrospective review of 20 patients who underwent primary osteoarticular allograft reconstruction after extremity sarcoma resection. All postoperative complications related to the allograft reconstruction were recorded. Musculoskeletal Tumor Society 1993 and Toronto Extremity Salvage Score scores were used for functional evaluation at last followup. Minimum followup was 10 years (mean, 16 years; range, 10-21 years). Seventy percent of patients experienced an event during the followup period. Recorded events were fracture (nine patients), progressive arthritis (five), nonunion (four), and infection (two). Sixty percent of allografts were removed at a mean of 5.2 years. Progressive arthritis led to total joint arthroplasty in five patients (25%). Mean Musculoskeletal Tumor Society and Toronto Extremity Salvage Score functional scores were 25 of 30 and 95% for patients who retained their original allograft. Osteoarticular allograft reconstruction for extremity sarcomas had a high rate of adverse events (70%) and allograft removal (60%) at long-term followup. Functional outcomes of patients with intact grafts were comparable to outcomes with segmental replacement prostheses reported in the literature.
Level IV, therapeutic study. See the Guidelines for Authors for a complete description of levels of evidence.
肢体肿瘤切除术后同种异体骨关节移植重建已显示出较高的并发症发生率。尽管已观察到良好的功能结果,但长期预后尚未得到充分研究。我们对20例肢体肉瘤切除术后接受初次同种异体骨关节移植重建的患者进行了回顾性研究。记录了所有与同种异体移植重建相关的术后并发症。在最后一次随访时,使用肌肉骨骼肿瘤学会1993年评分和多伦多肢体挽救评分进行功能评估。最短随访时间为10年(平均16年;范围10 - 21年)。70%的患者在随访期间发生了事件。记录的事件包括骨折(9例患者)、进行性关节炎(5例)、骨不连(4例)和感染(2例)。60%的同种异体移植在平均5.2年时被移除。进行性关节炎导致5例患者(25%)接受了全关节置换术。保留原同种异体移植的患者,肌肉骨骼肿瘤学会平均功能评分和多伦多肢体挽救评分分别为30分中的25分和95%。肢体肉瘤的同种异体骨关节移植重建在长期随访中不良事件发生率高(70%),同种异体移植移除率高(60%)。移植完整的患者的功能结果与文献报道的节段性置换假体的结果相当。
IV级,治疗性研究。有关证据水平的完整描述,请参见作者指南。